BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

951 related articles for article (PubMed ID: 19948396)

  • 1. MicroRNAs: predictors and modifiers of chemo- and radiotherapy in different tumour types.
    Hummel R; Hussey DJ; Haier J
    Eur J Cancer; 2010 Jan; 46(2):298-311. PubMed ID: 19948396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The roles of microRNA in cancer and apoptosis.
    Lynam-Lennon N; Maher SG; Reynolds JV
    Biol Rev Camb Philos Soc; 2009 Feb; 84(1):55-71. PubMed ID: 19046400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene expression profiling of drug-resistant small cell lung cancer cells by combining microRNA and cDNA expression analysis.
    Guo L; Liu Y; Bai Y; Sun Y; Xiao F; Guo Y
    Eur J Cancer; 2010 Jun; 46(9):1692-702. PubMed ID: 20371173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA function in cancer: oncogene or a tumor suppressor?
    Shenouda SK; Alahari SK
    Cancer Metastasis Rev; 2009 Dec; 28(3-4):369-78. PubMed ID: 20012925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of microRNAs in drug-resistant ovarian cancer cells.
    Sorrentino A; Liu CG; Addario A; Peschle C; Scambia G; Ferlini C
    Gynecol Oncol; 2008 Dec; 111(3):478-86. PubMed ID: 18823650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNAs: small but potent oncogenes or tumor suppressors.
    Lee YS; Dutta A
    Curr Opin Investig Drugs; 2006 Jun; 7(6):560-4. PubMed ID: 16784027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. OncomiRs: the discovery and progress of microRNAs in cancers.
    Cho WC
    Mol Cancer; 2007 Sep; 6():60. PubMed ID: 17894887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNAs and cancer.
    Cowland JB; Hother C; Grønbaek K
    APMIS; 2007 Oct; 115(10):1090-106. PubMed ID: 18042145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prognostic and chemotherapeutic value of miR-296 in esophageal squamous cell carcinoma.
    Hong L; Han Y; Zhang H; Li M; Gong T; Sun L; Wu K; Zhao Q; Fan D
    Ann Surg; 2010 Jun; 251(6):1056-63. PubMed ID: 20485139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-Fluorouracil and oxaliplatin modify the expression profiles of microRNAs in human colon cancer cells in vitro.
    Zhou J; Zhou Y; Yin B; Hao W; Zhao L; Ju W; Bai C
    Oncol Rep; 2010 Jan; 23(1):121-8. PubMed ID: 19956872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-181a and miR-630 regulate cisplatin-induced cancer cell death.
    Galluzzi L; Morselli E; Vitale I; Kepp O; Senovilla L; Criollo A; Servant N; Paccard C; Hupé P; Robert T; Ripoche H; Lazar V; Harel-Bellan A; Dessen P; Barillot E; Kroemer G
    Cancer Res; 2010 Mar; 70(5):1793-803. PubMed ID: 20145152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein lysate microarray analysis to identify microRNAs regulating estrogen receptor signaling in breast cancer cell lines.
    Leivonen SK; Mäkelä R; Ostling P; Kohonen P; Haapa-Paananen S; Kleivi K; Enerly E; Aakula A; Hellström K; Sahlberg N; Kristensen VN; Børresen-Dale AL; Saviranta P; Perälä M; Kallioniemi O
    Oncogene; 2009 Nov; 28(44):3926-36. PubMed ID: 19684618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. hsa-mir-181a and hsa-mir-181b function as tumor suppressors in human glioma cells.
    Shi L; Cheng Z; Zhang J; Li R; Zhao P; Fu Z; You Y
    Brain Res; 2008 Oct; 1236():185-93. PubMed ID: 18710654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stepwise up-regulation of microRNA expression levels from replicating to reversible and irreversible growth arrest states in WI-38 human fibroblasts.
    Maes OC; Sarojini H; Wang E
    J Cell Physiol; 2009 Oct; 221(1):109-19. PubMed ID: 19475566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miRNAs in cancer: approaches, aetiology, diagnostics and therapy.
    Blenkiron C; Miska EA
    Hum Mol Genet; 2007 Apr; 16 Spec No 1():R106-13. PubMed ID: 17613543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-330 acts as tumor suppressor and induces apoptosis of prostate cancer cells through E2F1-mediated suppression of Akt phosphorylation.
    Lee KH; Chen YL; Yeh SD; Hsiao M; Lin JT; Goan YG; Lu PJ
    Oncogene; 2009 Sep; 28(38):3360-70. PubMed ID: 19597470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Slowing down the Ras lane: miRNAs as tumor suppressors?
    Morris JP; McManus MT
    Sci STKE; 2005 Aug; 2005(297):pe41. PubMed ID: 16107327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A miR-200 microRNA cluster as prognostic marker in advanced ovarian cancer.
    Hu X; Macdonald DM; Huettner PC; Feng Z; El Naqa IM; Schwarz JK; Mutch DG; Grigsby PW; Powell SN; Wang X
    Gynecol Oncol; 2009 Sep; 114(3):457-64. PubMed ID: 19501389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNAs are involved in erythroid differentiation control.
    Yang GH; Wang F; Yu J; Wang XS; Yuan JY; Zhang JW
    J Cell Biochem; 2009 Jun; 107(3):548-56. PubMed ID: 19350553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of YB-1 on the regulation of micro RNA expression in drug-sensitive and drug-resistant gastric carcinoma cells.
    Belian E; Kurucz R; Treue D; Lage H
    Anticancer Res; 2010 Feb; 30(2):629-33. PubMed ID: 20332481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 48.